We are live on ! Find out more
Susquehanna International Group

Susquehanna International Group Portfolio holdings

AUM $1.28T
1-Year Est. Return 58.89%
 

Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+561.69%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
-$42.9B
Cap. Flow %
-7.42%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,658
Increased
4,874
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Technology 2.07%
2 Consumer Discretionary 1.49%
3 Financials 1.12%
4 Communication Services 1.1%
5 Healthcare 0.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADCT icon
11351
CALL
ADC Therapeutics
ADCT
$128M
$169K ﹤0.01%
11,500
-65,300
-85% -$1.04M
RYM
11352
RYTHM Inc
RYM
$45.3M
$169K ﹤0.01%
12
-31
-72% -$607K
GALT icon
11353
PUT
Galectin Therapeutics
GALT
$347M
$169K ﹤0.01%
105,100
-26,700
-20% -$51.7K
TRML
11354
DELISTED
Tourmaline Bio
TRML
$169K ﹤0.01%
+1,721
New +$161K
IRD
11355
Opus Genetics
IRD
$300M
$169K ﹤0.01%
52,123
-11,356
-18% -$38.9K
IMGN
11356
CALL
DELISTED
Immunogen Inc
IMGN
$169K ﹤0.01%
35,400
-176,400
-83% -$977K
HYRE
11357
CALL
DELISTED
HyreCar Inc. Common Stock
HYRE
$169K ﹤0.01%
70,800
-22,100
-24% -$68.3K
ZY
11358
PUT
DELISTED
Zymergen Inc. Common Stock
ZY
$169K ﹤0.01%
58,400
-73,900
-56% -$314K
KYN icon
11359
Kayne Anderson Energy Infrastructure Fund
KYN
$2.51B
$168K ﹤0.01%
18,183
-90,098
-83% -$765K
CURO
11360
DELISTED
CURO Group Holdings Corp.
CURO
$168K ﹤0.01%
12,870
-1,989
-13% -$27.4K
EVLO
11361
PUT
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$168K ﹤0.01%
+2,480
New +$206K
CRDF icon
11362
PUT
Cardiff Oncology
CRDF
$74.9M
$167K ﹤0.01%
67,500
-40,600
-38% -$144K
PHXM
11363
CALL
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$167K ﹤0.01%
9,200
-660
-7% -$12.5K
ACH
11364
DELISTED
Alum Corp of China Ltd
ACH
$167K ﹤0.01%
+11,512
New +$175K
CO
11365
DELISTED
Global Cord Blood Corporation
CO
$167K ﹤0.01%
43,547
+11,095
+34% +$46.1K
AREC icon
11366
PUT
American Resources Corp
AREC
$308M
$166K ﹤0.01%
64,700
-35,700
-36% -$72.4K
ARI
11367
Apollo Commercial Real Estate
ARI
$876M
$166K ﹤0.01%
11,903
-3,769
-24% -$50.8K
EMX
11368
DELISTED
EMX Royalty
EMX
$166K ﹤0.01%
76,516
+5,206
+7% +$11.5K
MERC icon
11369
CALL
Mercer International
MERC
$31.6M
$166K ﹤0.01%
+11,900
New +$153K
NGNE icon
11370
CALL
Neurogene
NGNE
$723M
$166K ﹤0.01%
4,420
-265
-6% -$15.5K
REVG
11371
CALL
DELISTED
REV Group
REVG
$166K ﹤0.01%
12,400
+1,200
+11% +$16.4K
SLNH icon
11372
Soluna Holdings
SLNH
$207M
$166K ﹤0.01%
+605
New +$151K
WT icon
11373
CALL
WisdomTree
WT
$3.46B
$166K ﹤0.01%
28,300
-132,400
-82% -$756K
XERS icon
11374
PUT
Xeris Biopharma Holdings
XERS
$1.57B
$166K ﹤0.01%
65,000
-26,500
-29% -$64.7K
ADAP
11375
DELISTED
Adaptimmune Therapeutics
ADAP
$165K ﹤0.01%
80,107
-31,981
-29% -$86.3K

Similar funds

Susquehanna International Group's Q1 2022 Portfolio in Review

As of Q1 2022, Susquehanna International Group held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Susquehanna International Group withdrew a net $42.9B in Q1 2022, closing 1,835 positions and reducing 6,001 holdings. Its most notable exit was Xilinx Inc, an estimated $217M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Susquehanna International Group opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $107M.

  • Susquehanna International Group's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Susquehanna International Group added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Susquehanna International Group's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Susquehanna International Group fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Susquehanna International Group's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Susquehanna International Group opened 1,658 new positions and closed 1,835 in Q1 2022.
  • Susquehanna International Group's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.